UBS raised its price target for Nutrien to $63, up from $62, but still says to sell the stock.

Nov 12, 2026, 2:06 PM ETOpinionRead the original at marketscreener.com

Neutral

UBS raised its price target for Nutrien from $62 to $63 but kept its Sell rating. The report gives no new business facts, so it does not change Nutrien's outlook.

NTR · Nutrien Ltd.

AI read · Neutral

The AI's read

The report changes only UBS's view of Nutrien's shares. A higher target points one way, but the retained Sell rating points the other. It adds no new facts about Nutrien's sales, costs, or operations.

Get alerts for NTR

Follow Nutrien Ltd. (NTR) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for NTR

Free on the App Store and Google Play, or on the web.